Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

Identifieur interne : 001C70 ( Main/Exploration ); précédent : 001C69; suivant : 001C71

The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known

Auteurs : David S. Fedson [France] ; J. Anthony [Royaume-Uni] ; G. Scott [États-Unis]

Source :

RBID : ISTEX:A23E3DC809ACCD308972665D8015A6B89B645124

Abstract

The burden of pneumococcal disease among adults in developed countries is neither widely known nor appreciated. The incidence of pneumococcal pneumonia is uncertain because a precise diagnosis cannot be obtained for most patients. Population-based data on invasive pneumococcal disease (e.g., bacteraemia and meningitis) suggest an annual incidence in all developed countries of ≥15–20 cases per 100,000 persons of all ages and ≥50 cases per 100,000 elderly adults (≥65 years). In developing countries there are no population-based data on the burden of pneumococcal disease among adults. Studies of high risk groups, hospital-based studies, vaccine efficacy trials, extrapolations from surveillance of “native populations” in developed countries, and demographic studies in developing regions all suggest a high burden of disease. The broad variation in these estimates, however, indicates that better studies are needed. Increased use of pneumococcal vaccines among adults in all countries will depend on better scientific and public understanding of the burden of pneumococcal disease. In developing countries, intensive community-based studies of the impact of pneumococcal disease, or, alternatively, a “vaccine probe” approach, in which a population is vaccinated and the reduction in pneumonia is compared with that in a control population, could give more accurate estimates of the burden of disease and of the potential effectiveness of pneumococcal vaccination among adults.

Url:
DOI: 10.1016/S0264-410X(99)00122-X


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known</title>
<author>
<name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S" last="Fedson">David S. Fedson</name>
</author>
<author>
<name sortKey="Anthony, J" sort="Anthony, J" uniqKey="Anthony J" first="J" last="Anthony">J. Anthony</name>
</author>
<author>
<name sortKey="Scott, G" sort="Scott, G" uniqKey="Scott G" first="G" last="Scott">G. Scott</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A23E3DC809ACCD308972665D8015A6B89B645124</idno>
<date when="1999" year="1999">1999</date>
<idno type="doi">10.1016/S0264-410X(99)00122-X</idno>
<idno type="url">https://api.istex.fr/document/A23E3DC809ACCD308972665D8015A6B89B645124/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">002054</idno>
<idno type="wicri:Area/Main/Curation">001D53</idno>
<idno type="wicri:Area/Main/Exploration">001C70</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known</title>
<author>
<name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S" last="Fedson">David S. Fedson</name>
<affiliation>
<wicri:noCountry code="no comma">E-mail: fedson@fr.vaxiline.com</wicri:noCountry>
</affiliation>
<affiliation wicri:level="1">
<country xml:lang="fr">France</country>
<wicri:regionArea>Pasteur-Mérieux MSD, 8 rue Jonas Salk, 69367, Lyon, Cedex 07</wicri:regionArea>
<wicri:noRegion>Cedex 07</wicri:noRegion>
<wicri:noRegion>Cedex 07</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Anthony, J" sort="Anthony, J" uniqKey="Anthony J" first="J" last="Anthony">J. Anthony</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Pasteur-Mérieux MSD, 8 rue Jonas Salk, 69367, Lyon, Cedex 07, FranceRespiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, USANuffield Department of Clinical Medicine,, University of Oxford, John Radcliffe Hospital, Oxford</wicri:regionArea>
<placeName>
<settlement type="city">Oxford</settlement>
<region type="country">Angleterre</region>
<region type="comté" nuts="2">Oxfordshire</region>
</placeName>
<orgName type="university">Université d'Oxford</orgName>
</affiliation>
</author>
<author>
<name sortKey="Scott, G" sort="Scott, G" uniqKey="Scott G" first="G" last="Scott">G. Scott</name>
<affiliation wicri:level="1">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta</wicri:regionArea>
<wicri:noRegion>Atlanta</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Vaccine</title>
<title level="j" type="abbrev">JVAC</title>
<idno type="ISSN">0264-410X</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1999">1999</date>
<biblScope unit="volume">17</biblScope>
<biblScope unit="supplement">S1</biblScope>
<biblScope unit="page" from="S11">S11</biblScope>
<biblScope unit="page" to="S18">S18</biblScope>
</imprint>
<idno type="ISSN">0264-410X</idno>
</series>
<idno type="istex">A23E3DC809ACCD308972665D8015A6B89B645124</idno>
<idno type="DOI">10.1016/S0264-410X(99)00122-X</idno>
<idno type="PII">S0264-410X(99)00122-X</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0264-410X</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The burden of pneumococcal disease among adults in developed countries is neither widely known nor appreciated. The incidence of pneumococcal pneumonia is uncertain because a precise diagnosis cannot be obtained for most patients. Population-based data on invasive pneumococcal disease (e.g., bacteraemia and meningitis) suggest an annual incidence in all developed countries of ≥15–20 cases per 100,000 persons of all ages and ≥50 cases per 100,000 elderly adults (≥65 years). In developing countries there are no population-based data on the burden of pneumococcal disease among adults. Studies of high risk groups, hospital-based studies, vaccine efficacy trials, extrapolations from surveillance of “native populations” in developed countries, and demographic studies in developing regions all suggest a high burden of disease. The broad variation in these estimates, however, indicates that better studies are needed. Increased use of pneumococcal vaccines among adults in all countries will depend on better scientific and public understanding of the burden of pneumococcal disease. In developing countries, intensive community-based studies of the impact of pneumococcal disease, or, alternatively, a “vaccine probe” approach, in which a population is vaccinated and the reduction in pneumonia is compared with that in a control population, could give more accurate estimates of the burden of disease and of the potential effectiveness of pneumococcal vaccination among adults.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>France</li>
<li>Royaume-Uni</li>
<li>États-Unis</li>
</country>
<region>
<li>Angleterre</li>
<li>Oxfordshire</li>
</region>
<settlement>
<li>Oxford</li>
</settlement>
<orgName>
<li>Université d'Oxford</li>
</orgName>
</list>
<tree>
<country name="France">
<noRegion>
<name sortKey="Fedson, David S" sort="Fedson, David S" uniqKey="Fedson D" first="David S" last="Fedson">David S. Fedson</name>
</noRegion>
</country>
<country name="Royaume-Uni">
<region name="Angleterre">
<name sortKey="Anthony, J" sort="Anthony, J" uniqKey="Anthony J" first="J" last="Anthony">J. Anthony</name>
</region>
</country>
<country name="États-Unis">
<noRegion>
<name sortKey="Scott, G" sort="Scott, G" uniqKey="Scott G" first="G" last="Scott">G. Scott</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C70 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C70 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:A23E3DC809ACCD308972665D8015A6B89B645124
   |texte=   The burden of pneumococcal disease among adults in developed and developing countries: what is and is not known
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024